Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Price:
3.1
USD
-4.62%
Market Cap:
$46.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
|
C
|
Chrysos Corporation Ltd
OTC:CHRCF
|
AU |
|
Osisko Gold Royalties Ltd
TSX:OR
|
CA |
|
Siemens Energy India Ltd
NSE:ENRIN
|
IN |
|
K
|
Keepers Holdings Inc
XPHS:KEEPR
|
PH |
|
Signify NV
AEX:LIGHT
|
NL |
|
S
|
Stonehenge Inter PCL
SET:STI
|
TH |
|
C
|
Chemring Group PLC
LSE:CHG
|
UK |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
F
|
Famous Brands Ltd
JSE:FBR
|
ZA |
|
FDM Group (Holdings) PLC
LSE:FDM
|
UK |
|
T
|
TimkenSteel Corp
NYSE:MTUS
|
US |
|
N
|
NNIT A/S
CSE:NNIT
|
DK |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
US |
|
S
|
Siam Pan Group PCL
SET:SPG
|
TH |
|
C
|
Capital Industrial Financial Services Group Ltd
HKEX:730
|
HK |
|
Daikokuya Holdings Co Ltd
TSE:6993
|
JP |
|
B
|
BCE Inc
NYSE:BCE
|
CA |
|
Global Partners LP
NYSE:GLP
|
US |
|
F
|
Fidere Patrimonio SOCIMI SA
MAD:YFID
|
ES |
|
Mphasis Ltd
NSE:MPHASIS
|
IN |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
E
|
E Automotive Inc
TSX:EINC
|
CA |
|
Varta AG
OTC:VARGF
|
DE |
Multiples-Based Value
The
Multiples-Based Value for
Cumberland Pharmaceuticals Inc (CPIX)
under the Base Case is
hidden
USD.
Compared with the current market price of 3.1 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CPIX Multiples-Based Value
LOCKED
Multiples Across Competitors
CPIX Competitors Multiples
Cumberland Pharmaceuticals Inc Competitors
Cumberland Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
46.4m USD | 1 | -16.3 | 29.7 | -14.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD | 13.5 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
